× Members

PIP

More
3 hours 46 minutes ago #312968 by Elizabeth Pyne
PIP was created by Elizabeth Pyne
My son has high functioning autism and also Fluoroquinolone Associated Disability. FQAD is a long lasting and possibly permanent physical and psychological disability caused by FQ antibiotics. There are now prescribing restrictions on these awful drugs. He has just had his PIP reviewed and has been awarded the enhanced rates for daily living and mobility for an 'ongoing period'. Does anyone know what this may mean, possibly no further review in the future? I thought no awards were given for more than ten years? Could this be due to the awaited outcome of the Timms review?
Such a relief, thanks so much for the information on this website and for the excellent training modules.

Please Log in or Create an account to join the conversation.

More
2 hours 44 minutes ago #312971 by BIS
Replied by BIS on topic PIP
Hi Elizabeth Pyne

So glad to hear that your son has been given an ongoing award. If there is no date for a review on the decision letter, the award will last for ten years, and he should be sent a Light Touch Review form sometime after that. The review is most likely to be a paper-based review (though it's not an absolute certainty). So there still aren't awards longer than ten years - it's just a slightly different process from those that have been given a review date and there is an expectation that his needs will continue.

BIS

Nothing on this board constitutes legal advice - always consult a professional about specific problems

Please Log in or Create an account to join the conversation.

Moderators: latetrainBISCatherine12345ChrisDavidForum Moderator
We use cookies

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.